| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 19 | 2018 | 959 | 3.790 |
Why?
|
| Amyotrophic Lateral Sclerosis | 15 | 2017 | 1484 | 2.550 |
Why?
|
| Hypoxia-Ischemia, Brain | 6 | 2017 | 361 | 1.870 |
Why?
|
| Melatonin | 6 | 2018 | 674 | 1.570 |
Why?
|
| Spinal Cord | 8 | 2015 | 1784 | 1.510 |
Why?
|
| Serotonin | 4 | 2018 | 1049 | 1.380 |
Why?
|
| Receptor, Melatonin, MT1 | 4 | 2018 | 31 | 1.130 |
Why?
|
| Apoptosis | 25 | 2018 | 9514 | 0.970 |
Why?
|
| Methazolamide | 3 | 2016 | 9 | 0.950 |
Why?
|
| Frizzled Receptors | 3 | 2014 | 86 | 0.940 |
Why?
|
| Wnt Proteins | 3 | 2013 | 722 | 0.930 |
Why?
|
| SOX9 Transcription Factor | 4 | 2018 | 146 | 0.920 |
Why?
|
| Cell Death | 14 | 2015 | 1679 | 0.900 |
Why?
|
| Cytochromes c | 7 | 2015 | 173 | 0.880 |
Why?
|
| Tryptophan | 2 | 2015 | 483 | 0.840 |
Why?
|
| Superoxide Dismutase | 8 | 2015 | 593 | 0.840 |
Why?
|
| Mitochondria | 13 | 2015 | 3673 | 0.810 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2017 | 504 | 0.760 |
Why?
|
| Huntington Disease | 5 | 2011 | 1147 | 0.720 |
Why?
|
| HMGB1 Protein | 2 | 2014 | 139 | 0.690 |
Why?
|
| Brain Ischemia | 7 | 2018 | 3000 | 0.650 |
Why?
|
| Neurons | 14 | 2017 | 9525 | 0.630 |
Why?
|
| MicroRNAs | 5 | 2018 | 3785 | 0.620 |
Why?
|
| Neural Stem Cells | 3 | 2017 | 898 | 0.620 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2017 | 485 | 0.610 |
Why?
|
| Caspase 1 | 4 | 2009 | 227 | 0.610 |
Why?
|
| Caspases | 10 | 2015 | 880 | 0.600 |
Why?
|
| Astrocytes | 5 | 2017 | 1345 | 0.600 |
Why?
|
| Cytoprotection | 2 | 2014 | 200 | 0.540 |
Why?
|
| Wnt1 Protein | 2 | 2014 | 120 | 0.530 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 43 | 0.520 |
Why?
|
| Caspase 3 | 8 | 2016 | 731 | 0.520 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2016 | 118 | 0.520 |
Why?
|
| Hydrogen Peroxide | 3 | 2014 | 743 | 0.510 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 282 | 0.510 |
Why?
|
| Disease Models, Animal | 21 | 2017 | 18293 | 0.500 |
Why?
|
| Motor Neurons | 3 | 2015 | 869 | 0.500 |
Why?
|
| Pemphigus | 3 | 2006 | 107 | 0.480 |
Why?
|
| Brain Edema | 2 | 2016 | 602 | 0.470 |
Why?
|
| Substantia Nigra | 1 | 2016 | 346 | 0.470 |
Why?
|
| Hemin | 1 | 2014 | 51 | 0.450 |
Why?
|
| Cerebellar Nuclei | 1 | 2014 | 55 | 0.450 |
Why?
|
| Brain Injuries | 2 | 2018 | 2060 | 0.450 |
Why?
|
| Animals | 55 | 2019 | 168764 | 0.440 |
Why?
|
| Mice, Transgenic | 12 | 2017 | 9550 | 0.420 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4392 | 0.420 |
Why?
|
| Globins | 1 | 2014 | 406 | 0.420 |
Why?
|
| Keratinocytes | 4 | 2004 | 863 | 0.400 |
Why?
|
| Oxidative Stress | 5 | 2018 | 3141 | 0.390 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2009 | 93 | 0.380 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 335 | 0.370 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 316 | 0.370 |
Why?
|
| Antioxidants | 5 | 2013 | 1670 | 0.360 |
Why?
|
| Mice | 33 | 2019 | 81819 | 0.360 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 72 | 0.360 |
Why?
|
| Autophagy | 3 | 2017 | 1351 | 0.350 |
Why?
|
| Drug Design | 1 | 2015 | 1042 | 0.340 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 286 | 0.340 |
Why?
|
| Liver Diseases | 1 | 2018 | 1303 | 0.340 |
Why?
|
| Neuroglia | 2 | 2015 | 964 | 0.340 |
Why?
|
| Stroke | 5 | 2018 | 9747 | 0.330 |
Why?
|
| Blotting, Western | 9 | 2019 | 5020 | 0.330 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 774 | 0.320 |
Why?
|
| Membrane Potential, Mitochondrial | 5 | 2014 | 292 | 0.320 |
Why?
|
| Osteoporosis | 1 | 2018 | 1582 | 0.310 |
Why?
|
| Reperfusion Injury | 2 | 2013 | 1042 | 0.310 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1022 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 11888 | 0.300 |
Why?
|
| Cells, Cultured | 12 | 2017 | 18973 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 8102 | 0.300 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 113 | 0.300 |
Why?
|
| Acantholysis | 2 | 2006 | 11 | 0.300 |
Why?
|
| Stem Cell Transplantation | 2 | 2017 | 1602 | 0.290 |
Why?
|
| Neurogenesis | 1 | 2014 | 866 | 0.280 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 752 | 0.280 |
Why?
|
| Autoantibodies | 3 | 2006 | 2113 | 0.280 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1218 | 0.280 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1490 | 0.270 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10429 | 0.270 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1241 | 0.270 |
Why?
|
| beta Catenin | 1 | 2012 | 1043 | 0.270 |
Why?
|
| Stem Cells | 4 | 2017 | 3540 | 0.270 |
Why?
|
| Signal Transduction | 13 | 2019 | 23601 | 0.270 |
Why?
|
| Enzyme Activation | 8 | 2014 | 3586 | 0.270 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 366 | 0.270 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 256 | 0.260 |
Why?
|
| Neurodegenerative Diseases | 4 | 2011 | 1087 | 0.260 |
Why?
|
| Caspase 9 | 4 | 2014 | 184 | 0.260 |
Why?
|
| Cognition Disorders | 2 | 2019 | 3967 | 0.260 |
Why?
|
| Chloride Channels | 2 | 2019 | 221 | 0.260 |
Why?
|
| Deep Brain Stimulation | 1 | 2014 | 850 | 0.250 |
Why?
|
| Ischemia | 1 | 2014 | 1909 | 0.250 |
Why?
|
| Carrier Proteins | 5 | 2008 | 4913 | 0.240 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11022 | 0.240 |
Why?
|
| Oxidopamine | 2 | 2016 | 168 | 0.240 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2018 | 84 | 0.240 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2015 | 133 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1657 | 0.230 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2016 | 365 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1333 | 0.220 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2013 | 610 | 0.210 |
Why?
|
| Sleep | 1 | 2018 | 4813 | 0.200 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2140 | 0.200 |
Why?
|
| Glioma | 4 | 2018 | 3493 | 0.200 |
Why?
|
| Minocycline | 1 | 2003 | 168 | 0.200 |
Why?
|
| Epidermis | 2 | 2004 | 538 | 0.190 |
Why?
|
| Cell Survival | 4 | 2016 | 5747 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3401 | 0.190 |
Why?
|
| Transfection | 5 | 2016 | 5743 | 0.180 |
Why?
|
| Bromodeoxyuridine | 3 | 2017 | 310 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 1132 | 0.180 |
Why?
|
| Membrane Potentials | 2 | 2017 | 1083 | 0.180 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1037 | 0.170 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2001 | 200 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2016 | 1066 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 18071 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2017 | 2927 | 0.160 |
Why?
|
| Brain | 5 | 2014 | 27171 | 0.160 |
Why?
|
| Hippocampus | 3 | 2017 | 3775 | 0.160 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 31 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 22332 | 0.150 |
Why?
|
| Rats | 7 | 2017 | 23707 | 0.150 |
Why?
|
| Membrane Transport Modulators | 1 | 2017 | 24 | 0.150 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 3 | 2006 | 32 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11641 | 0.150 |
Why?
|
| Liver | 1 | 2013 | 7562 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 66 | 0.140 |
Why?
|
| Nortriptyline | 2 | 2008 | 78 | 0.140 |
Why?
|
| Hexokinase | 1 | 2017 | 125 | 0.140 |
Why?
|
| Dynamins | 1 | 2017 | 138 | 0.140 |
Why?
|
| Cerebral Cortex | 6 | 2017 | 5767 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5783 | 0.140 |
Why?
|
| Sympatholytics | 1 | 2016 | 81 | 0.130 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 51 | 0.130 |
Why?
|
| Time Factors | 8 | 2014 | 40065 | 0.130 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 1028 | 0.130 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 3 | 2006 | 146 | 0.130 |
Why?
|
| Cell Line | 6 | 2019 | 15543 | 0.130 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 365 | 0.130 |
Why?
|
| Dendrites | 1 | 2019 | 469 | 0.130 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 9071 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3690 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3421 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2014 | 4137 | 0.120 |
Why?
|
| Hybrid Cells | 1 | 2015 | 421 | 0.120 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 132 | 0.120 |
Why?
|
| Dacarbazine | 1 | 2018 | 552 | 0.120 |
Why?
|
| Enkephalin, Leucine | 1 | 2014 | 15 | 0.120 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 42 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2006 | 3067 | 0.120 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2014 | 63 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 259 | 0.120 |
Why?
|
| Neurotensin | 1 | 2014 | 59 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 614 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 564 | 0.110 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 82 | 0.110 |
Why?
|
| Humans | 38 | 2018 | 765968 | 0.110 |
Why?
|
| Vasospasm, Intracranial | 1 | 2016 | 206 | 0.110 |
Why?
|
| Substance P | 1 | 2015 | 331 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12768 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 434 | 0.110 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 142 | 0.110 |
Why?
|
| Male | 25 | 2019 | 363698 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.110 |
Why?
|
| Malondialdehyde | 1 | 2013 | 112 | 0.110 |
Why?
|
| Riluzole | 1 | 2013 | 62 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2014 | 246 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 379 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 167 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1884 | 0.100 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 528 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 9525 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2019 | 548 | 0.100 |
Why?
|
| Biological Assay | 1 | 2016 | 627 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2016 | 705 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1118 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 238 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 328 | 0.100 |
Why?
|
| Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2601 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2014 | 1151 | 0.100 |
Why?
|
| Mutation | 3 | 2013 | 30198 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 415 | 0.100 |
Why?
|
| Permeability | 1 | 2014 | 726 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2011 | 119 | 0.090 |
Why?
|
| Choline | 1 | 2013 | 510 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2013 | 488 | 0.090 |
Why?
|
| Creatine | 1 | 2013 | 424 | 0.090 |
Why?
|
| Lentivirus | 1 | 2014 | 518 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 506 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2013 | 576 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1995 | 0.090 |
Why?
|
| Oncogenes | 1 | 2016 | 1235 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4562 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 431 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 13400 | 0.090 |
Why?
|
| Cell Movement | 3 | 2017 | 5194 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3715 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 1673 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 212 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2009 | 412 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 1445 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1314 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 2002 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 858 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2012 | 449 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1140 | 0.080 |
Why?
|
| Regeneration | 1 | 2018 | 1517 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1599 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1886 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17594 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 3051 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2011 | 445 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7851 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 1216 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2009 | 256 | 0.080 |
Why?
|
| Neural Tube | 1 | 2009 | 48 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8611 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 663 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1718 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1745 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2428 | 0.080 |
Why?
|
| Disease Progression | 4 | 2013 | 13632 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2844 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2014 | 909 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6203 | 0.070 |
Why?
|
| Mitochondrial Membranes | 1 | 2009 | 184 | 0.070 |
Why?
|
| Pentachlorophenol | 1 | 2007 | 10 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 12807 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 874 | 0.070 |
Why?
|
| Phenanthrolines | 1 | 2007 | 48 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1393 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1884 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2009 | 1546 | 0.070 |
Why?
|
| Maze Learning | 2 | 2019 | 482 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2008 | 187 | 0.070 |
Why?
|
| Caspases, Initiator | 1 | 2006 | 31 | 0.070 |
Why?
|
| Cytotoxins | 1 | 2007 | 154 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 777 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2060 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2016 | 4025 | 0.060 |
Why?
|
| Meningioma | 1 | 2014 | 1221 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2016 | 1663 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3564 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2009 | 1984 | 0.060 |
Why?
|
| Cricetinae | 1 | 2009 | 2411 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3797 | 0.060 |
Why?
|
| Caspase 6 | 2 | 2001 | 15 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1748 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 367 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3404 | 0.060 |
Why?
|
| COS Cells | 1 | 2006 | 1136 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6069 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 927 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26346 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 186 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1808 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 214 | 0.050 |
Why?
|
| Axons | 1 | 2011 | 1682 | 0.050 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.050 |
Why?
|
| Gene Expression | 2 | 2009 | 7584 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14448 | 0.050 |
Why?
|
| Receptors, Death Domain | 1 | 2003 | 31 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3672 | 0.050 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2867 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 13024 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 317 | 0.050 |
Why?
|
| Weight Loss | 1 | 2014 | 2710 | 0.050 |
Why?
|
| Female | 14 | 2018 | 396112 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1243 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3634 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 17075 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10070 | 0.050 |
Why?
|
| Proteins | 2 | 2015 | 5995 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3459 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2567 | 0.050 |
Why?
|
| Models, Biological | 2 | 2009 | 9443 | 0.050 |
Why?
|
| Motor Activity | 1 | 2011 | 2704 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 48 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2268 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 440 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 65188 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 18380 | 0.040 |
Why?
|
| Longevity | 1 | 2008 | 1087 | 0.040 |
Why?
|
| Complement C5a | 1 | 2000 | 98 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 812 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1410 | 0.040 |
Why?
|
| Glycosylation | 1 | 2003 | 1100 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 880 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2745 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3602 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1240 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12131 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 110 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1644 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3807 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2669 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 542 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 663 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6499 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1652 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 17 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6274 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 545 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 219 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1261 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1966 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 16721 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1770 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 610 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 369 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2007 | 4214 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 623 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 912 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 793 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3737 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6001 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3750 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2019 | 6424 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2942 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1998 | 1039 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 297 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4528 | 0.020 |
Why?
|
| Middle Aged | 7 | 2018 | 223009 | 0.020 |
Why?
|
| Antigens | 1 | 2017 | 1438 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4348 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3607 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10850 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2548 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2406 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2243 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3618 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6220 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2476 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6113 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 594 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2014 | 1180 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 8041 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 223044 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4734 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 24282 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 30260 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 708 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29922 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2606 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1689 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9591 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2880 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 426 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5881 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4209 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 788 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 2410 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10603 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4671 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7421 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12056 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5337 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1749 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6255 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 975 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12509 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 647 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8731 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 123 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 2584 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 1999 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2000 | 102 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 1308 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 380 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2648 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 1069 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 283 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 572 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 414 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36532 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1998 | 355 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1724 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1998 | 439 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2966 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 822 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 376 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4241 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16047 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4335 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 2260 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5767 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1998 | 962 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2218 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1202 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9347 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2000 | 2485 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4475 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 88835 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74840 | 0.000 |
Why?
|
| Aged | 2 | 2017 | 171117 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4520 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 59889 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5501 | 0.000 |
Why?
|
| Child | 1 | 2014 | 80564 | 0.000 |
Why?
|